Decomposing the Energetic Impact of Drug Resistant Mutations in HIV-1 Protease on Binding DRV-Reference-Cited by-同舟云学术

Decomposing the Energetic Impact of Drug Resistant Mutations in HIV-1 Protease on Binding DRV

Published:2010-03-04 Issue:4 Volume:6 Page:1358-1368
ISSN:1549-9618
Container-title:Journal of Chemical Theory and Computation
language:en
Short-container-title:J. Chem. Theory Comput.

Author:

Cai Yufeng¹,Schiffer Celia A.¹

Affiliation:

1. Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, Massachusetts 01605

Publisher

American Chemical Society (ACS)

Subject

Physical and Theoretical Chemistry,Computer Science Applications

Link

https://pubs.acs.org/doi/pdf/10.1021/ct9004678

Reference66 articles.

1. The HIV-1 Protease as a Therapeutic Target for AIDS

2. STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASE

3. Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme

4. Structural and Thermodynamic Basis for the Binding of TMC114, a Next-Generation Human Immunodeficiency Virus Type 1 Protease Inhibitor

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. d-α-tocopheryl polyethylene glycol succinate-decorated dual drug-loaded lipidic nanocarriers: A strategic approach for targeting lymphatic uptake and p-gp efflux modulation to enhance oral bioavailability in HIV-1 viral reservoirs;Journal of Drug Delivery Science and Technology;2024-09

2. Advanced molecular mechanisms of modified DRV compounds in targeting HIV-1 protease mutations and interrupting monomer dimerization;Physical Chemistry Chemical Physics;2024

3. Evolving Mutational Buildup in HIV-1 Protease Shifts Conformational Dynamics to Gain Drug Resistance;Journal of Chemical Information and Modeling;2023-06-07

4. Effects of the G48M mutant on the dynamics properties and binding mechanism of PR with SQV and ATV;Molecular Simulation;2022-03-28

5. A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2);International Journal of Biological Macromolecules;2021-07